AIMP1 and pancreatic neoplasm: It has been reported that EMAP II inhibited the growth of endothelial cells and pancreatic cancer cells, and the inhibitory effect was associated with the inhibition of tumor vascular endothelium growth (Schwarz and Schwarz, 2004).